Related Experiment Videos
Structural determinants of rotavirus subgroup specificity mapped by cryo-electron microscopy
Sarah L Greig1, John A Berriman, Judith A O'Brien
1School of Biological Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
Journal of Molecular Biology
|December 20, 2005
Summary
Rotavirus double-layered particles (DLPs) from different subgroups exhibit varying transcriptase activity. Structural differences in VP6 trimers, particularly at 5-fold axes, correlate with this activity, impacting viral mRNA synthesis.
Area of Science:
- Virology
- Structural Biology
- Molecular Machines
Background:
- Rotavirus double-layered particles (DLPs) are essential for viral replication, transcribing genomic RNA into mRNA.
- Significant differences in transcriptase activity exist between human Wa (subgroup II) and bovine UK (subgroup I) rotavirus DLPs.
Purpose of the Study:
- To elucidate the structural basis for differential transcriptase activity between rotavirus subgroups.
- To investigate the role of VP6 layer structure in rotavirus mRNA synthesis.
Main Methods:
- Cryo-electron microscopy and icosahedral image analysis were employed to generate 3D density maps of DLPs.
- Subgroup-specific monoclonal antibodies and Fab fragments were used to probe structural variations.
- X-ray structures were docked into cryo-EM maps for pseudo-atomic resolution analysis.
Main Results:
- Both bovine UK and human Wa DLPs share similar overall dimensions and VP6 trimer size.
- Human Wa DLPs exhibit a notable absence of VP6 trimers at 5-fold vertex positions compared to bovine UK DLPs.
- The study identified subgroup-specific epitopes and proposed their locations within the VP6 structure.
Conclusions:
- A direct correlation exists between the VP6 layer structure and rotavirus DLP transcriptase activity.
- The stability of VP6 trimers, especially at icosahedral 5-fold axes, is crucial for efficient mRNA synthesis.
- Rotavirus subgroup specificity may arise from architectural variations in DLPs, influencing viral mRNA production.